* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Subcut Fluids Summary - Harrogate and Rural District CCG
Survey
Document related concepts
Transcript
Subcut fluids made simple in Primary Care Background The administration of subcutaneous fluids can provide a safe and effective way of clinically assisting with hydration and symptom control for palliative care patients who are unable to take, or absorb, adequate oral fluids. For detailed protocol in place for community nursing team see the HDFT Clinically Assisted Hydration in Palliative Care policy May 2016. This includes guidance for clinicians on Indications for use of subcutaneous fluids and references to national guidance. There is also GMC guidance which can be found here GMC - Treatment and care towards the end of life. Prescription should be by an appropriately qualified medical practitioner or registered non-medical prescriber. If the patient is known to the Specialist Palliative Care team a multi-disciplinary discussion and agreement that clinically assisted hydration is in the patient's best interests should be held prior to these being commenced. The Specialist Palliative Care Team are available for advice/consultation if required for any palliative patient where you are considering subcut fluids. A recent urea and electrolyte result may aid decision making regarding appropriateness for CAH and whether IV fluids may be more appropriate. If normal Urea and electrolyte results and patient is not clinically dehydrated then explanations about the use and limitations of CAH may avoid false expectations for patients and families. Up to two litres of fluid a day may be administered subcutaneously. It is more likely that problems will be fewer if one to two litres are given over 24 hours. If the patient is able to take oral fluids, then one litre subcutaneously over 24 hours may be sufficient. Fluids can be administered continuously or over smaller periods of time if more convenient for the patient. Fluids cannot be prescribed on an FP10. Equipment required: GP Subcutaneous Fluids Replacement Therapy Chart (WHZ066) available via district nursing teams or will be supplied with patient if discharged from HDFT on CAH. GP needs to prescribe on this. District Nursing Teams Subcutaneous fluid site monitoring sheet also available via district nursing teams or will be supplied with patient if discharged from HDFT on CAH. infusion fluid available via HDFT inpatient pharmacy department or the vanguard hubs at Hornbeam park, Harrogate or Ripon hospital (awaiting confirmation). Please call in advance to order and they will ensure the fluid is available to collect. If the patient is being discharged from HDFT a box of fluid will be supplied on discharge. Saf-T-Intima subcutaneous cannula Standard intravenous administration giving set as used by the service available via HDFT or vanguard hubs. A semi-permeable transparent adhesive film dressing Sharps container Single use disposable non-sterile gloves Single use disposable apron Bionector Stand for the administration of fluids 2% Chlorhexidine/70% alcohol impregnated wipe Water for injection How to prescribe: Prescribe on a Fluids Replacement Therapy Chart (WHZ066) on the fluid replacement page stating that fluids should be administered subcutaneously. The charts are available via district nursing teams, or will be supplied with patient if discharged from HDFT on CAH (also see Appendix 1) What to prescribe: Current local guidance on what fluids to use is: 0.9% Sodium Chloride should be prescribed in either 500ml or 1000ml volumes. Please discuss with Specialist Palliative Care team if unsure what to prescribe. Parenteral fluids should be tailored to the clinical indication for which they are required, the route they will be given via and the individual patient. If giving fluid subcutaneously, potassium should not currently be given but other electrolytes should be given e.g. 0.45% sodium chloride and 5% glucose. If there are existing deficits or excesses, ongoing abnormal losses or abnormal fluid distribution, these need to be taken into account in addition. Fluids that should not be given via subcutaneous administration • Colloids • Blood or blood products • Total parental nutrition ( TPN ) 2 • Solutions with added medication • Glucose solutions > 5% • Solutions containing potassium Volume of fluid: Daily fluid volume requirements should be calculated using the guidance below • • 20-25ml/kg/day if older, frail, renal imp, cardiac failure, malnourished. 25-30 ml/kg/day normal population (obese patients use ideal body weight)*. Palliative care patients will often be malnourished and frail. In addition they often have low albumin levels and increased levels of ADH with a tendency to retain water. Therefore, unless there is good reason, they should not usually be given more than 20ml/kg/day including oral intake of fluid/medications etc. Lesser volumes are acceptable if the aim of treatment is not simply replacing daily volume requirements e.g. treatment of a dry mouth, or if there are signs of fluid overload and a more cautious approach is required. Preparing the patient and family: Explain the procedure, indications and aims of subcutaneous fluids to the patient and/or relatives. This is to remove any misconceptions around the use of subcutaneous fluids, advising them that they are used only to alleviate symptoms when the patient is unable to swallow oral fluids and IV fluids are inappropriate or impractical. They should be informed that ongoing blood monitoring may be required once fluids are commenced to monitor effects This discussion and reasoning should be clearly documented. Prescribing Hyalase: If the site of subcut fluid infusion needs frequent changes, discuss with the specialist palliative care team whether the infusion should continue or consider the addition of Hyaluronidase to aid the absorption of the infusion. Hyaluronidase is an enzyme that has a temporary and reversible depolymerising effect on the polysaccharide hyaluronic acid, which is present in the intercellular matrix of connective tissue. 3 Prescribe as 1500iu of Hyalase® dissolved in 1ml of water for injections, or normal saline, injected into the site, before the infusion is set up, or injected into the tubing of the infusion set. This should be prescribed on the community palliative care medication chart (syringe driver chart) in the regular/prn medication section (WHZ061) An FP10 will be required to obtain this from a community pharmacy.1500iu is sufficient for administration of 500-1000ml of most fluids. Chris Ranson, HaRD CCG Senior Pharmacist Dr Sarah Hay, GP Governing Body HaRD CCG October 2016 Version 2.0 4